Skip Header

 

1 - 25 of 67 results for author:"Perry M."Drop in Literature Citations

Customize display Download...

Page of 3 | Next »

Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.

Deblois G., Hall J.A., Perry M.C., Laganiere J., Ghahremani M., Park M., Hallett M., Giguere V.

Cancer Res. 69:6149-6157(2009) · Mapped (6)

Skeletal muscle fiber types in the ghost crab, Ocypode quadrata: implications for running performance.

Perry M.J., Tait J., Hu J., White S.C., Medler S.

J. Exp. Biol. 212:673-683(2009) · UniProtKB (3)

Does adiposity status influence femoral cortical strength in rodent models of growth hormone deficiency?

Stevenson A.E., Evans B.A., Gevers E.F., Elford C., McLeod R.W., Perry M.J., El-Kasti M.M., Coschigano K.T., Kopchick J.J., Evans S.L. et al.

Am. J. Physiol. Endocrinol. Metab. 296:E147-56(2009) · Mapped (4)

The peroxisome proliferator activator receptor alpha/delta agonists linoleic acid and bezafibrate upregulate osteoblast differentiation and induce periosteal bone formation in vivo.

Still K., Grabowski P., Mackie I., Perry M., Bishop N.

Calcif. Tissue Int. 83:285-292(2008) · Mapped (4)

S-nitrosylated S100A8: novel anti-inflammatory properties.

Lim S.Y., Raftery M., Cai H., Hsu K., Yan W.X., Hseih H.L., Watts R.N., Richardson D., Thomas S., Perry M. et al.

J. Immunol. 181:5627-5636(2008) · Mapped (5)

A single amino acid difference between ether-a-go-go- related gene channel subtypes determines differential sensitivity to a small molecule activator.

Perry M., Sanguinetti M.C.

Mol. Pharmacol. 73:1044-1051(2008) · Mapped (14)

CYP2E1 substrate inhibition. Mechanistic interpretation through an effector site for monocyclic compounds.

Collom S.L., Laddusaw R.M., Burch A.M., Kuzmic P., Perry M.D. Jr., Miller G.P.

J. Biol. Chem. 283:3487-3496(2008) · Mapped (11)

Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses.

Gramolini A.O., Kislinger T., Alikhani-Koopaei R., Fong V., Thompson N.J., Isserlin R., Sharma P., Oudit G.Y., Trivieri M.G., Fagan A. et al.

Mol. Cell Proteomics 7:519-533(2008) · Mapped (1)

An ENU-induced mutation in the Ankrd11 gene results in an osteopenia-like phenotype in the mouse mutant Yoda.

Barbaric I., Perry M.J., Dear T.N., Rodrigues Da Costa A., Salopek D., Marusic A., Hough T., Wells S., Hunter A.J., Cheeseman M. et al.

Physiol. Genomics 32:311-321(2008) · Mapped (10)

Impaired growth plate function in bmp-6 null mice.

Perry M.J., McDougall K.E., Hou S.C., Tobias J.H.

Bone 42:216-225(2008) · Mapped (2)

Osteopenia in Sparc (osteonectin)-deficient mice: characterization of phenotypic determinants of femoral strength and changes in gene expression.

Mansergh F.C., Wells T., Elford C., Evans S.L., Perry M.J., Evans M.J., Evans B.A.

Physiol. Genomics 32:64-73(2007) · Mapped (3)

Poly-N-acetylglucosamine mediates biofilm formation and detergent resistance in Aggregatibacter actinomycetemcomitans.

Izano E.A., Sadovskaya I., Wang H., Vinogradov E., Ragunath C., Ramasubbu N., Jabbouri S., Perry M.B., Kaplan J.B.

Microb. Pathog. 44:52-60(2008) · UniProtKB (6)

Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator.

Perry M., Sachse F.B., Sanguinetti M.C.

Proc. Natl. Acad. Sci. U.S.A. 104:13827-13832(2007) · Mapped (13)

Pharmacological regulation of adult stem cells: chondrogenesis can be induced using a synthetic inhibitor of the retinoic acid receptor.

Kafienah W., Mistry S., Perry M.J., Politopoulou G., Hollander A.P.

Stem Cells 25:2460-2468(2007) · Mapped (3)

Mice with a disruption of the imprinted Grb10 gene exhibit altered body composition, glucose homeostasis, and insulin signaling during postnatal life.

Smith F.M., Holt L.J., Garfield A.S., Charalambous M., Koumanov F., Perry M., Bazzani R., Sheardown S.A., Hegarty B.D., Lyons R.J. et al.

Mol. Cell. Biol. 27:5871-5886(2007) · Mapped (4)

High-dose estrogen-induced osteogenesis is decreased in aged RUNX2(+/-) mice.

Juttner K.V., Perry M.J.

Bone 41:25-32(2007) · Mapped (3)

Tumor suppression and normal aging in mice with constitutively high p53 activity.

Mendrysa S.M., O'Leary K.A., McElwee M.K., Michalowski J., Eisenman R.N., Powell D.A., Perry M.E.

Genes Dev. 20:16-21(2006) · Mapped (5)

Monocarboxylate transporter MCT1 is a target for immunosuppression.

Murray C.M., Hutchinson R., Bantick J.R., Belfield G.P., Benjamin A.D., Brazma D., Bundick R.V., Cook I.D., Craggs R.I., Edwards S. et al.

Nat. Chem. Biol. 1:371-376(2005) · Mapped (9)

Inhibition of zebrafish fin regeneration using in vivo electroporation of morpholinos against fgfr1 and msxb.

Thummel R., Bai S., Sarras M.P. Jr., Song P., McDermott J., Brewer J., Perry M., Zhang X., Hyde D.R., Godwin A.R.

Dev. Dyn. 235:336-346(2006) · Mapped (1)

Haplotypes of the low-density lipoprotein receptor-related protein 5 (LRP5) gene: are they a risk factor in osteoarthritis?

Smith A.J., Gidley J., Sandy J.R., Perry M.J., Elson C.J., Kirwan J.R., Spector T.D., Doherty M., Bidwell J.L., Mansell J.P.

Osteoarthr. Cartil. 13:608-613(2005) · Mapped (2)

Ketogenic diet fed rats have low levels of S100B in cerebrospinal fluid.

Ziegler D.R., Oliveira D.L., Pires C., Ribeiro L., Leite M., Mendez A., Goncalves D., Tramontina F., Portela L.V., Wofchuk S.T. et al.

Neurosci. Res. 50:375-379(2004) · Mapped (1)

Extended haplotypes and linkage disequilibrium in the IL1R1-IL1A-IL1B-IL1RN gene cluster: association with knee osteoarthritis.

Smith A.J., Keen L.J., Billingham M.J., Perry M.J., Elson C.J., Kirwan J.R., Sims J.E., Doherty M., Spector T.D., Bidwell J.L.

Genes Immun. 5:451-460(2004) · Mapped (12)

Multinucleated osteoclast formation in vivo and in vitro by P2X7 receptor-deficient mice.

Gartland A., Buckley K.A., Hipskind R.A., Perry M.J., Tobias J.H., Buell G., Chessell I., Bowler W.B., Gallagher J.A.

Crit. Rev. Eukaryot. Gene Expr. 13:243-253(2003) · Mapped (10)

Mdm2 regulates p53 independently of p19(ARF) in homeostatic tissues.

O'Leary K.A., Mendrysa S.M., Vaccaro A., Perry M.E.

Mol. Cell. Biol. 24:186-191(2004) · Mapped (19)

Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin.

Ashcroft A.J., Cruickshank S.M., Croucher P.I., Perry M.J., Rollinson S., Lippitt J.M., Child J.A., Dunstan C., Felsburg P.J., Morgan G.J. et al.

Immunity 19:849-861(2003) · Mapped (11)

Page of 3 | Next »